These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7664348)

  • 61. Functional liposomal membranes for triggered release.
    Koçer A
    Methods Mol Biol; 2010; 605():243-55. PubMed ID: 20072885
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs.
    Liu F; Liu D
    Pharm Res; 1995 Jul; 12(7):1060-4. PubMed ID: 7494803
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
    Gabizon A; Papahadjopoulos D
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6949-53. PubMed ID: 3413128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis.
    Corvo ML; Boerman OC; Oyen WJ; Van Bloois L; Cruz ME; Crommelin DJ; Storm G
    Biochim Biophys Acta; 1999 Jul; 1419(2):325-34. PubMed ID: 10407083
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In-vivo studies on dexamethasone sodium phosphate liposomes.
    Al-Muhammed J; Ozer AY; Ercan MT; Hincal AA
    J Microencapsul; 1996; 13(3):293-306. PubMed ID: 8860685
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Large unilamellar liposomes with low uptake into the reticuloendothelial system.
    Allen TM; Chonn A
    FEBS Lett; 1987 Oct; 223(1):42-6. PubMed ID: 3666140
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prolongation of liposome circulation time by various derivatives of polyethyleneglycols.
    Yuda T; Maruyama K; Iwatsuru M
    Biol Pharm Bull; 1996 Oct; 19(10):1347-51. PubMed ID: 8913510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeted liposomal drug delivery in cancer.
    Medina OP; Zhu Y; Kairemo K
    Curr Pharm Des; 2004; 10(24):2981-9. PubMed ID: 15379663
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of drug delivery systems in cancer chemotherapy.
    Juliano RL
    Prog Clin Biol Res; 1976; 9():21-32. PubMed ID: 1030801
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An imaging-driven model for liposomal stability and circulation.
    Qin S; Seo JW; Zhang H; Qi J; Curry FR; Ferrara KW
    Mol Pharm; 2010 Feb; 7(1):12-21. PubMed ID: 19621944
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rates of systemic degradation and reticuloendothelial system uptake of calcein in the dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols in mice.
    Qi XR; Maitani Y; Nagai T
    Pharm Res; 1995 Jan; 12(1):49-52. PubMed ID: 7724487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice.
    Ishida O; Maruyama K; Sasaki K; Iwatsuru M
    Int J Pharm; 1999 Nov; 190(1):49-56. PubMed ID: 10528096
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Selective delivery of drugs encapsulated in liposomes: natural targeting to macrophages involved in various disease states.
    Schroit AJ; Hart IR; Madsen J; Fidler IJ
    J Biol Response Mod; 1983; 2(2):97-100. PubMed ID: 6644336
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Size-controlled long-circulating PICsome as a ruler to measure critical cut-off disposition size into normal and tumor tissues.
    Anraku Y; Kishimura A; Kobayashi A; Oba M; Kataoka K
    Chem Commun (Camb); 2011 Jun; 47(21):6054-6. PubMed ID: 21519616
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Suppression of the reticuloendothelial system using λ-carrageenan to prolong the circulation of gold nanoparticles.
    Magaña IB; Yendluri RB; Adhikari P; Goodrich GP; Schwartz JA; Sherer EA; O'Neal DP
    Ther Deliv; 2015 Jul; 6(7):777-83. PubMed ID: 26228771
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fate and behavior of liposomes in vivo: a review of controlling factors.
    Senior JH
    Crit Rev Ther Drug Carrier Syst; 1987; 3(2):123-93. PubMed ID: 3542245
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A lymphotropic colloidal carrier system for diethylcarbamazine: preparation and performance evaluation.
    Karajgi JS; Vyas SP
    J Microencapsul; 1994; 11(5):539-45. PubMed ID: 7815271
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Long circulation liposome and nuclear medicine].
    Ma C; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):941-5. PubMed ID: 17899779
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-circulating liposomes of indomethacin in arthritic rats--a biodisposition study.
    Srinath P; Chary MG; Vyas SP; Diwan PV
    Pharm Acta Helv; 2000 Apr; 74(4):399-404. PubMed ID: 10812940
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma.
    Tokudome Y; Oku N; Doi K; Namba Y; Okada S
    Biochim Biophys Acta; 1996 Feb; 1279(1):70-4. PubMed ID: 8624364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.